SCHEMBL5951704

SCHEMBL5951704

CC1Cc2c(cccc2-c2ccccc2-c2ccccc2)C1=O

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.60
BRD4 O60885 2/20 0.40
CREBBP Q92793 1/20 0.40
PARP10 Q53GL7 1/20 0.38
PARP11 Q9NR21 1/20 0.38
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
HTR1A P08908 2/20 0.37
HTR7 P34969 2/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
CSNK2A2 P19784 1/20 0.37
CSNK2A1 P68400 1/20 0.37
ANPEP P15144 1/20 0.36
IL1RN P18510 1/20 0.36
ERAP2 Q6P179 1/20 0.36
ERAP1 Q9NZ08 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3066323 0.93 ACHE (0.64) ACHEBRD4CREBBPPARP10PARP11
SCHEMBL5952058 0.90 ACHE (0.60) ACHEBRD4CREBBPPARP10PARP11
SCHEMBL5952357 0.84 ACHE (0.57) ACHEBRD4CREBBPPARP10PARP11
SCHEMBL5952394 0.84 ACHE (0.57) ACHEBRD4CREBBPHCRTR1HCRTR2
SCHEMBL5952316 0.81 ACHE (0.77) ACHEBRD4PARP10PARP11HTR7
SCHEMBL5952009 0.81 ACHE (0.62) ACHEBRD4CSNK2A2CSNK2A1
SCHEMBL5952816 0.80 ACHE (0.54) ACHEBRD4CREBBP
SCHEMBL5952877 0.80 ACHE (0.60) ACHEBRD4CSNK2A2CSNK2A1
SCHEMBL5952480 0.80 ACHE (0.56) ACHEBRD4CREBBPPARP10PARP11
SCHEMBL5951545 0.80 ACHE (0.65) ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3022238-B1 METALLOCENES AND CATALYST COMPOSITIONS DERIVED THEREFROM EXXONMOBIL CHEMICAL PATENTS INC (US) 2017-09-20 EP disclosed
EP-3022238-B1 METALLOCENES AND CATALYST COMPOSITIONS DERIVED THEREFROM EXXONMOBIL CHEMICAL PATENTS INC (US) 2017-09-20 EP disclosed
US-9745390-B2 Metallocenes and catalyst compositions derived therefrom EXXONMOBIL CHEMICAL PATENTS INC. (US) 2017-08-29 US disclosed
US-9745390-B2 Metallocenes and catalyst compositions derived therefrom EXXONMOBIL CHEMICAL PATENTS INC. (US) 2017-08-29 US disclosed
US-9745390-B2 Metallocenes and catalyst compositions derived therefrom EXXONMOBIL CHEMICAL PATENTS INC. (US) 2017-08-29 US disclosed
EP-3022238-A1 METALLOCENES AND CATALYST COMPOSITIONS DERIVED THEREFROM ExxonMobil Chemical Patents Inc. (US) 2016-05-25 EP disclosed
US-20160130374-A1 Metallocenes and Catalyst Compositions Derived Therefrom EXXONMOBIL CHEMICAL PATENTS INC. 2016-05-12 US disclosed
US-20160130374-A1 Metallocenes and Catalyst Compositions Derived Therefrom EXXONMOBIL CHEMICAL PATENTS INC. 2016-05-12 US disclosed
US-20160130374-A1 Metallocenes and Catalyst Compositions Derived Therefrom EXXONMOBIL CHEMICAL PATENTS INC. 2016-05-12 US disclosed
US-9249239-B2 Metallocenes and catalyst compositions derived therefrom EXXONMOBIL CHEMICAL PATENTS INC. (US) 2016-02-02 US disclosed
WO-2015009470-A1 METALLOCENES AND CATALYST COMPOSITIONS DERIVED THEREFROM EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-01-22 WO disclosed
US-20150025205-A1 Metallocenes and Catalyst Compositions Derived Tehrefrom EXXONMOBIL CHEMICAL PATENTS INC. 2015-01-22 US disclosed
US-20150025205-A1 Metallocenes and Catalyst Compositions Derived Tehrefrom EXXONMOBIL CHEMICAL PATENTS INC. 2015-01-22 US disclosed
US-20150025205-A1 Metallocenes and Catalyst Compositions Derived Tehrefrom EXXONMOBIL CHEMICAL PATENTS INC. 2015-01-22 US disclosed
WO-2015009470-A1 METALLOCENES AND CATALYST COMPOSITIONS DERIVED THEREFROM EXXONMOBIL CHEMICAL PATENTS INC. (US) 2015-01-22 WO disclosed
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150025205-A1 Metallocenes and Catalyst Compositions Derived Tehrefrom TERF2, TERT, TERF2IP ACHE 2798/4885BRD4 173/4885CREBBP 2918/4885
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A ACHE 839/4885BRD4 3097/4885CREBBP 2331/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 ACHE 820/4885BRD4 3045/4885CREBBP 2466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.